Literature DB >> 10978330

Identification of basic residues involved in drug export function of human multidrug resistance-associated protein 2.

S Ryu1, T Kawabe, S Nada, A Yamaguchi.   

Abstract

Multidrurg resistance-associated protein 2 (MRP2)/canalicular multispecific organic anion transporter (cMOAT) is involved in the ATP-dependent export of organic anions across the bile canalicular membrane. To identify functional amino acid residues that play essential roles in the substrate transport, each of 13 basic residues around transmembrane regions (TMs) 6-17 were replaced with alanine. Wild type and mutant proteins were expressed in COS-7 cells, and the transport activity was measured as the excretion of glutathione-methylfluorescein. Four mutants, K324A (TM6), K483A (TM9), R1210A (TM16), and R1257A (TM17), showed decreased transport activity, and another mutant, K578A (TM11), showed decreased protein expression. These five mutants were normally delivered to the cell surface similar to the other fully active mutants and wild type MRP2. The importance of TM6, TM16, and TM17 in the transport function of MRP2 is consistent with the previous observation indicating the importance of the corresponding TM1, TM11, and TM12 on P-glycoprotein (Loo, T. W., and Clarke, D. M. (1999) J. Biol. Chem. 274, 35388-35392). Another observation that MRP2 inhibitor, cyclosporine A, failed to inhibit R1230A specifically, indicated the existence of its binding site within TM16.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978330     DOI: 10.1074/jbc.M005149200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.

Authors:  Xia Wen; Melanie S Joy; Lauren M Aleksunes
Journal:  Pharm Res       Date:  2017-04-12       Impact factor: 4.200

2.  Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.

Authors:  Oliver Müller; Carmen Schalla; Jürgen Scheibner; Eduard F Stange; Michael Fuchs
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 3.  Multidrug Resistance Proteins (MRPs) and Cancer Therapy.

Authors:  Yun-Kai Zhang; Yi-Jun Wang; Pranav Gupta; Zhe-Sheng Chen
Journal:  AAPS J       Date:  2015-04-04       Impact factor: 4.009

Review 4.  Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.

Authors:  Zhe-Sheng Chen; Amit K Tiwari
Journal:  FEBS J       Date:  2011-08-01       Impact factor: 5.542

5.  Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.

Authors:  Xiaokun Cai; Zsolt Bikadi; Zhanglin Ni; Eun-Woo Lee; Honggang Wang; Mark F Rosenberg; Qingcheng Mao
Journal:  J Pharmacol Exp Ther       Date:  2010-03-04       Impact factor: 4.030

6.  Photoaffinity labeling of the multidrug resistance protein 2 (ABCC2/cMOAT) with a photoreactive analog of LTC(4).

Authors:  Mara L Leimanis; Joel Karwatsky; Elias Georges
Journal:  Int J Biochem Mol Biol       Date:  2010-12-15

7.  Tobacco carcinogen NNK transporter MRP2 regulates CFTR function in lung epithelia: implications for lung cancer.

Authors:  Chunying Li; John D Schuetz; Anjaparavanda P Naren
Journal:  Cancer Lett       Date:  2010-01-20       Impact factor: 8.679

8.  Localization of the GSH-dependent photolabelling site of an agosterol A analog on human MRP1.

Authors:  Xiao-Qin Ren; Tatsuhiko Furukawa; Shunji Aoki; Tomoyuki Sumizawa; Misako Haraguchi; Xiao-Fang Che; Motomasa Kobayashi; Shin-ichi Akiyama
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 9.  Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.

Authors:  Li Xing; Yiding Hu; Yurong Lai
Journal:  AAPS J       Date:  2009-06-03       Impact factor: 4.009

10.  Toxicity of xanthene food dyes by inhibition of human drug-metabolizing enzymes in a noncompetitive manner.

Authors:  Takaharu Mizutani
Journal:  J Environ Public Health       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.